Troglitazone Reduces Glyoxalase I Protein Expression in Glioma and Potentiates the Effects of Chemotherapeutic Agents
Figure 4
A representative experiment showing cell viability time course with treatment of U-373 cells with TRG, 300 M BCNU, and TRG/300 M BCNU together at 25 (a), 50 (b), and 100 (c) M concentrations of TRG. Combination treatments found to potentiate cytotoxicity are marked with an asterisk; other concentrations were found to be additive. Each data point is the mean and SEM of seven wells treated at the specified condition.
